Literature DB >> 14523464

Unsolved issues in CLL biology and management.

G Dighiero1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14523464     DOI: 10.1038/sj.leu.2403154

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia.

Authors:  William G Wierda; Thomas J Kipps; Jan Dürig; Laimonas Griskevicius; Stephan Stilgenbauer; Jirí Mayer; Lukás Smolej; Georg Hess; Rasa Griniute; Francisco J Hernandez-Ilizaliturri; Swaminathan Padmanabhan; Michele Gorczyca; Chai-Ni Chang; Geoffrey Chan; Ira Gupta; Tina G Nielsen; Charlotte A Russell
Journal:  Blood       Date:  2011-04-15       Impact factor: 22.113

2.  Myelodysplastic Syndrome and Acute Lymphocytic Leukemia in Common Variable Immunodeficiency (CVID).

Authors:  Jennifer Toh; Rachel Eisenberg; Kamila Bakirhan; Amit Verma; Arye Rubinstein
Journal:  J Clin Immunol       Date:  2016-03-18       Impact factor: 8.317

3.  Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.

Authors:  Douglas E Gladstone; Lode Swinnen; Yvette Kasamon; Amanda Blackford; Christopher D Gocke; Constance A Griffin; Javier Bolanos Meade; Richard J Jones
Journal:  Leuk Lymphoma       Date:  2011-08-18

Review 4.  Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.

Authors:  Douglas E Gladstone; Ephraim Fuchs
Journal:  Curr Opin Oncol       Date:  2012-03       Impact factor: 3.645

5.  Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory Model.

Authors:  Travis D Westbrook; Eleshia J Morrison; Kami J Maddocks; Farrukh T Awan; Jeffrey A Jones; Jennifer A Woyach; Amy J Johnson; John C Byrd; Barbara L Andersen
Journal:  Ann Behav Med       Date:  2019-08-16

6.  A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.

Authors:  José Angel Hernández; Ana Eugenia Rodríguez; Marcos González; Rocío Benito; Celia Fontanillo; Virgilio Sandoval; Mercedes Romero; Guillermo Martín-Núñez; Alfonso García de Coca; Rosa Fisac; Josefina Galende; Isabel Recio; Francisco Ortuño; Juan Luis García; Javier de las Rivas; Norma Carmen Gutiérrez; Jesús F San Miguel; Jesús María Hernández
Journal:  Haematologica       Date:  2009-03       Impact factor: 9.941

7.  To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients.

Authors:  Jaroslaw Piszcz; Emily G Armitage; Alessia Ferrarini; Francisco J Rupérez; Agnieszka Kulczynska; Lukasz Bolkun; Janusz Kloczko; Adam Kretowski; Alina Urbanowicz; Michal Ciborowski; Coral Barbas
Journal:  Oncotarget       Date:  2016-04-19

8.  Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.

Authors:  Heng Li; Shu-Hua Yi; Wen-Jie Xiong; Hui-Min Liu; Rui Lyu; Ting-Yu Wang; Wei Liu; Shi-Zhen Zhong; Zhen Yu; De-Hui Zou; Yan Xu; Gang An; Zeng-Jun Li; Lu-Gui Qiu
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

Review 9.  Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.

Authors:  Daniel Prieto; Pablo Oppezzo
Journal:  Molecules       Date:  2017-12-05       Impact factor: 4.411

10.  Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.

Authors:  Ana Eugenia Rodríguez; Jose Ángel Hernández; Rocío Benito; Norma C Gutiérrez; Juan Luis García; María Hernández-Sánchez; Alberto Risueño; M Eugenia Sarasquete; Encarna Fermiñán; Rosa Fisac; Alfonso García de Coca; Guillermo Martín-Núñez; Natalia de Las Heras; Isabel Recio; Oliver Gutiérrez; Javier De Las Rivas; Marcos González; Jesús M Hernández-Rivas
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.